X0407 4 2023-05-15 0000313143 HAEMONETICS CORP HAE 0001950021 Galvin Roy 125 SUMMER STREET BOSTON MA 02110 1 President, Global Plasma & BC 0 Common Stock 2023-05-15 4 A 0 2243 A 4689 D Non-qualified Stock Option (Right to Buy) 89.16 2023-05-15 4 A 0 5068 0 A 2030-05-15 Common Stock 5068 5068 D The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant. Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. This number includes unvested RSUs previously reported as well as 64 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 28, 2023. Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. /s/ Thomas V. Powers, attorney-in-fact for Mr. Galvin 2023-05-17